In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Mayo Foundation for Medical Education & Research

Division of Mayo Clinic

Latest From Mayo Foundation for Medical Education & Research

Nile Therapeutics Inc.

For patients with acute decompensated heart failure, Nile Therapeutics is developing a drug related to known natriuretic peptides, which addresses three important mechanisms. CD-NP shows promise in fluid unloading, but without the side effect of low blood pressure that often accompanies other medications; it as the potential to reduce filling pressure; and it may also preserve, or possibly enhance, renal function.

Recent Financings of Private Companies (09/2006)

Each month, Start-Up presents a comprehensive review of young, private life science companies that have recieved venture funding during the month, including companies in the pharmaceutical, medical device, diagnostic and research instrumentation & reagent sectors.

Recent Tech Transfer Deals (1/06)

St. Jude Medical: Dealing Its Way to the Top in AF

St. Jude Medical's recent announcement that it will acquire Endocardial Solutions represents the latest step in St. Jude's aggressive strategy to become a dominant player in the atrial fibrillation (AF) market.
Medical Device Innovation
See All